Some directors and senior executives of Zhejiang Haisen Pharmaceutical (001367.SZ) plan to reduce their holdings by a total of no more than 124,300 shares.
Haisen Pharmaceutical (001367.SZ) announced that some directors and senior management of the company plan to collectively reduce their holdings of the company's shares by 124,300 shares (0.0816% of the total share capital) through centralized bidding trading within 3 months after 15 trading days from the disclosure of this announcement (from December 26, 2025 to March 25, 2026).
Zhejiang Haisen Pharmaceutical (001367.SZ) announced that some directors and senior management of the company plan to collectively reduce their holdings of the company's shares by a total of 12.43 million shares (0.0816% of the total share capital) through centralized competitive trading within 3 months after 15 trading days from the date of this announcement, from December 26, 2025 to March 25, 2026.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
